For Western blotting, cells were lysed in RIPA buffer [50 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 1% NP-40, 2 mmol/L EDTA, 0.5% Na Deoxycholate, and 0.1% SDS] supplemented with
protease and phosphatase inhibitor cocktail (Cell Signaling Technology, #5872s). Protein concentrations were measured with
BCA Protein Assay Kit (Sangon Biotech, #C503021). For Western blotting, equal amounts of protein were heat denatured in the presence of a reducing agent and separated on 4%–12% or 10% Bis-Tris SurePAGE gels (GeneScript, #M00652, #M00665), and transferred to PVDF membranes. Antibodies used for Western blotting were as follows: anti-mouse MAN2A1 Antibody (Santa Cruz Biotechnology, #sc-376909), anti-human MAN2A1 antibody (Santa Cruz Biotechnology, #sc-377204),
pSTAT1 (Cell Signaling Technology, #9167),
STAT1 (Cell Signaling Technology, #9172), ERK2 (Santa Cruz Biotechnology, #sc-1647),
GAPDH (Sigma, #G9545),
PD-L1 (E1L3N) XP Rabbit mAb (Cell Signaling Technology, #13684T),
vinculin (Santa Cruz Biotechnology, #sc-73614),
Goat anti-rabbit secondary antibody (Cell Signaling Technology, #7074s), and
Goat anti-mouse secondary antibody (Cell Signaling Technology, #7076s). The blots were imaged using CLINX imaging system according to the manufacturer’s instruction.
Shi S., Gu S., Han T., Zhang W., Huang L., Li Z., Pan D., Fu J., Ge J., Brown M., Zhang P., Jiang P., Wucherpfennig K.W, & Liu X.S. (2020). Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(22), 5990-6002.